ADVAGEN, a Singapore based company founded in 2006 which develops and markets healthcare supplements and pharmaceuticals, is pleased to announce its chemotherapeutic product, Pemetrexed ADVAGEN, is now approved in Singapore. “We are pleased to be able to provide a wider range of safe, effective and affordable treatment options with the addition of Pemetrexed ADVAGEN in Singapore. We will […]

Read More…

ADVAGEN, a company which develops and markets healthcare supplements and pharmaceuticals, is pleased to announce its dietary fiber supplement Fibrosol is now available on online marketplace Lazada and Shopee. “We are happy to provide another channel for our users to obtain their supply of Fibrosol. Online marketplaces allow our users to make their purchase anytime […]

Read More…

ADVAGEN, a Singapore based company founded in 2006 which develops and markets healthcare supplements and pharmaceuticals, is pleased to announce its chemotherapeutic product, Irinotecan ADVAGEN, is now approved in Singapore. “We are extremely pleased to receive the registration approval for Irinotecan ADVAGEN. It was a challenging process but knowing the benefits it provides to patients in Singapore […]

Read More…

ADVAGEN, a company which develops and markets healthcare supplements and pharmaceuticals, is pleased to announce it launched its dietary fiber supplement Fibrosol in Hong Kong today. Fibrosol, a daily corn-based soluble dietary fiber supplement for optimum digestive health, is introduced to leading medical practitioners at leading private medical centres, clinics and hospitals. Its unique features, benefits and effectiveness […]

Read More…

ADVAGEN, a Singapore based company founded in 2006 which develops and markets healthcare supplements and pharmaceuticals, is pleased to announce the approval of BiCNU® (Carmustine for injection), a chemotherapeutic product, in Singapore. “We are indeed happy to obtain the registration approval of BiCNU® in Singapore. It has been more than 2 years since we first submitted the […]

Read More…